Viewing Study NCT01708603


Ignite Creation Date: 2025-12-24 @ 7:32 PM
Ignite Modification Date: 2026-06-14 @ 10:19 AM
Study NCT ID: NCT01708603
Status: TERMINATED
Last Update Posted: 2020-01-06
First Post: 2012-09-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis
Sponsor: Bausch Health Americas, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Moderate to Severe Plaque Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None psoriasis, brodalumab, AMG 827 View